Russell Investments Group
NEOS

Russell Investments Group’s Neos Therapeutics, Inc NEOS Stock Holding History

Russell Investments Group’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-580,391
Closed -$874K – 3204
2019
Q4 		$874K Buy
+580,391
New +$871K ﹤0.01% 2169
2019
Q3 		– Sell
-200
Closed – – 3139
2019
Q2 		$0 Buy
+200
New +$368 ﹤0.01% 3008
2018
Q4 		– Sell
-386,962
Closed -$1.88M – 3082
2018
Q3 		$1.88M Sell
386,962
-228,712
-37% -$1.3M ﹤0.01% 1795
2018
Q2 		$3.85M Sell
615,674
-213,624
-26% -$1.59M 0.01% 1412
2018
Q1 		$6.88M Buy
829,298
+329,128
+66% +$3.14M 0.01% 1178
2017
Q4 		$4.98M Buy
500,170
+226,083
+82% +$2.17M 0.01% 1350
2017
Q3 		$2.51M Buy
274,087
+4,067
+2% +$30.9K ﹤0.01% 1655
2017
Q2 		$1.97M Buy
270,020
+169,237
+168% +$1.28M ﹤0.01% 1745
2017
Q1 		$725K Buy
100,783
+13,527
+16% +$83.9K ﹤0.01% 2273
2016
Q4 		$545K Buy
+87,256
New +$590K ﹤0.01% 2438

Other funds holding NEOS

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Russell Investments Group's NEOS Position: Q1 2020 in Review

Russell Investments Group sold out of Neos Therapeutics, Inc (NEOS) in Q1 2020, closing a stake of 580,391 shares — an estimated $874K sold.

Russell Investments Group first reported a position in NEOS in Q4 2016 and held it in 10 quarters. The position peaked at $6.88M in Q1 2018. 49 funds tracked by Wall St. Rank hold NEOS as of Q1 2020.

  • Russell Investments Group reported no remaining Neos Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Russell Investments Group sold 580,391 Neos Therapeutics, Inc shares in Q1 2020, an estimated $874K.
  • Russell Investments Group first reported a position in Neos Therapeutics, Inc in Q4 2016 and held it in 10 quarters.
  • Russell Investments Group's Neos Therapeutics, Inc position peaked at $6.88M in Q1 2018.
  • 49 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2020.

Based on Russell Investments Group's 13F filing for Q1 2020, filed 6 May 2020.